Activity Description & Educational Objectives
In this activity, an expert in the management of Parkinson’s disease uses two case scenarios to provide practical recommendations on the management of worsening motor symptoms and motor complications in patients with advanced Parkinson’s disease.
Upon completion of this activity, participants should be better able to:
- Apply evidence-based strategies for the management of motor symptoms in patients with advanced Parkinson’s disease
- Identify the practical utility of adjunctive medications and rescue therapies for the management of motor complications in patients with advanced Parkinson’s disease
This activity has been designed to meet the educational needs of neurologists and other clinicians involved in the management of Parkinson’s disease.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Release and Expiration Dates: March 05, 2013 - March 04, 2014
Time to Complete: 45 minutes
Faculty & Disclosure / Conflict of Interest Policy
In accordance with ACCME requirements, the University of Florida College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Course Director and Interviewee
Ramon L. Rodriguez, MD
Director of Clinics and Clinical Trials, Center for Movement Disorders and Neurorestoration
Director, Tyler’s Hope Center for Dystonia Care
Clinical Associate Professor, Neurology
University of Florida College of Medicine
Ramon L. Rodriguez, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Abbott Laboratories; Allergan, Inc.; Biotie Therapies; EMD Serono, Inc.; Huntington Study Group; Ipsen; Merz Pharmaceuticals, LLC; National Institutes of Health; National Institute of Neurological Disorders and Stroke; National Parkinson Foundation; NeuroNova; and Teva Pharmaceuticals USA. Dr. Rodriguez has no owner interest in any pharmaceutical company.
Honoraria from Corporate Meeting Solutions, LLC.; Lundbeck, Inc.; Merz Pharmaceuticals, LLC; PRIME Education, Inc.; PVI, PeerView Institute for Medical Education; and Teva Pharmaceuticals USA.
Other Financial or Material Support from The University of Florida Clinic has contracts with Allergan for education services provided by Dr. Rodriguez, but he does not receive any personal compensation for these roles.
Kalina Sanders, MD
Assistant Professor of Neurology
University of Florida College of Medicine – Jacksonville
Kalina Sanders, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for EMD Serono, Inc.
Speakers Bureau participant with EMD Serono, Inc./Pfizer, Inc.; Biogen Idec; Teva Pharmaceuticals, Ltd.; and Novartis Pharmaceuticals Corporation.
All financial relationships listed above have ended as of June 2012.
Christopher Washburn, PhD
PVI, PeerView Institute for Medical Education
Christopher Washburn, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.
Sponsorship, Credit & Support
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity is jointly sponsored by the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.